0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and China Human Papillomavirus(HPV) Vaccines Market Insights, Forecast to 2027
Published Date: August 2021
|
Report Code: QYRE-Auto-36T6697
Home | Market Reports | Health | Pharmacy
Global and China Human Papillomavirus HPV Vaccines Market Insights Forecast to 2027

Global and China Human Papillomavirus(HPV) Vaccines Market Insights, Forecast to 2027

Code: QYRE-Auto-36T6697
Report
August 2021
Pages:127
QYResearch
Description
Table of Content
Tables & Figures

Human Papillomavirus(HPV) Vaccines Market Statistics 2027

Human Papillomavirus(HPV) Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Papillomavirus(HPV) Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Human Papillomavirus(HPV) Vaccines market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

  • 2-Valent Vaccine
  • 4-Valent Vaccine

Segment by Application

  • Research & Academic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others

BY REGION

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

BY COMPANY

  • Merck
  • GSK
  • Walvax
1 Study Coverage
1.1 Human Papillomavirus(HPV) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Human Papillomavirus(HPV) Vaccines Market Size Growth Rate by Type
1.2.2 2-Valent Vaccine
1.2.3 4-Valent Vaccine
1.3 Market by Application
1.3.1 Global Human Papillomavirus(HPV) Vaccines Market Size Growth Rate by Application
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Papillomavirus(HPV) Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Human Papillomavirus(HPV) Vaccines Revenue 2016-2027
2.1.2 Global Human Papillomavirus(HPV) Vaccines Sales 2016-2027
2.2 Global Human Papillomavirus(HPV) Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Human Papillomavirus(HPV) Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Human Papillomavirus(HPV) Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Human Papillomavirus(HPV) Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Human Papillomavirus(HPV) Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Human Papillomavirus(HPV) Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Human Papillomavirus(HPV) Vaccines Revenue Forecast by Region (2022-2027)
3 Global Human Papillomavirus(HPV) Vaccines Competitor Landscape by Players
3.1 Global Top Human Papillomavirus(HPV) Vaccines Manufacturers by Sales
3.1.1 Global Human Papillomavirus(HPV) Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Human Papillomavirus(HPV) Vaccines Manufacturers by Revenue
3.2.1 Key Human Papillomavirus(HPV) Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Human Papillomavirus(HPV) Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Human Papillomavirus(HPV) Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Human Papillomavirus(HPV) Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Human Papillomavirus(HPV) Vaccines Revenue in 2020
3.2.6 Global Human Papillomavirus(HPV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Human Papillomavirus(HPV) Vaccines Price by Manufacturers
3.4 Global Human Papillomavirus(HPV) Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Human Papillomavirus(HPV) Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Papillomavirus(HPV) Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Human Papillomavirus(HPV) Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Human Papillomavirus(HPV) Vaccines Market Size by Type (2016-2021)
4.1.1 Global Human Papillomavirus(HPV) Vaccines Sales by Type (2016-2021)
4.1.2 Global Human Papillomavirus(HPV) Vaccines Revenue by Type (2016-2021)
4.1.3 Human Papillomavirus(HPV) Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Human Papillomavirus(HPV) Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Human Papillomavirus(HPV) Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Human Papillomavirus(HPV) Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Human Papillomavirus(HPV) Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Human Papillomavirus(HPV) Vaccines Market Size by Application (2016-2021)
5.1.1 Global Human Papillomavirus(HPV) Vaccines Sales by Application (2016-2021)
5.1.2 Global Human Papillomavirus(HPV) Vaccines Revenue by Application (2016-2021)
5.1.3 Human Papillomavirus(HPV) Vaccines Price by Application (2016-2021)
5.2 Human Papillomavirus(HPV) Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Human Papillomavirus(HPV) Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Human Papillomavirus(HPV) Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Papillomavirus(HPV) Vaccines Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Human Papillomavirus(HPV) Vaccines Market Size YoY Growth 2016-2027
6.1.1 China Human Papillomavirus(HPV) Vaccines Sales YoY Growth 2016-2027
6.1.2 China Human Papillomavirus(HPV) Vaccines Revenue YoY Growth 2016-2027
6.1.3 China Human Papillomavirus(HPV) Vaccines Market Share in Global Market 2016-2027
6.2 China Human Papillomavirus(HPV) Vaccines Market Size by Players (International and Local Players)
6.2.1 China Top Human Papillomavirus(HPV) Vaccines Players by Sales (2016-2021)
6.2.2 China Top Human Papillomavirus(HPV) Vaccines Players by Revenue (2016-2021)
6.3 China Human Papillomavirus(HPV) Vaccines Historic Market Review by Type (2016-2021)
6.3.1 China Human Papillomavirus(HPV) Vaccines Sales Market Share by Type (2016-2021)
6.3.2 China Human Papillomavirus(HPV) Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 China Human Papillomavirus(HPV) Vaccines Price by Type (2016-2021)
6.4 China Human Papillomavirus(HPV) Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Human Papillomavirus(HPV) Vaccines Sales Forecast by Type (2022-2027)
6.4.2 China Human Papillomavirus(HPV) Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 China Human Papillomavirus(HPV) Vaccines Price Forecast by Type (2022-2027)
6.5 China Human Papillomavirus(HPV) Vaccines Historic Market Review by Application (2016-2021)
6.5.1 China Human Papillomavirus(HPV) Vaccines Sales Market Share by Application (2016-2021)
6.5.2 China Human Papillomavirus(HPV) Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 China Human Papillomavirus(HPV) Vaccines Price by Application (2016-2021)
6.6 China Human Papillomavirus(HPV) Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Human Papillomavirus(HPV) Vaccines Sales Forecast by Application (2022-2027)
6.6.2 China Human Papillomavirus(HPV) Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 China Human Papillomavirus(HPV) Vaccines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Human Papillomavirus(HPV) Vaccines Market Size YoY Growth 2016-2027
7.2 North America Human Papillomavirus(HPV) Vaccines Market Facts & Figures by Country
7.2.1 North America Human Papillomavirus(HPV) Vaccines Sales by Country (2016-2021)
7.2.2 North America Human Papillomavirus(HPV) Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Human Papillomavirus(HPV) Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Human Papillomavirus(HPV) Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Human Papillomavirus(HPV) Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Human Papillomavirus(HPV) Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Human Papillomavirus(HPV) Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Human Papillomavirus(HPV) Vaccines Market Facts & Figures by Country
9.2.1 Europe Human Papillomavirus(HPV) Vaccines Sales by Country (2016-2021)
9.2.2 Europe Human Papillomavirus(HPV) Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Human Papillomavirus(HPV) Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Human Papillomavirus(HPV) Vaccines Market Facts & Figures by Country
10.2.1 Latin America Human Papillomavirus(HPV) Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Human Papillomavirus(HPV) Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Human Papillomavirus(HPV) Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Human Papillomavirus(HPV) Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Papillomavirus(HPV) Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Human Papillomavirus(HPV) Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Human Papillomavirus(HPV) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Human Papillomavirus(HPV) Vaccines Products Offered
12.1.5 Merck Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Description and Business Overview
12.2.3 GSK Human Papillomavirus(HPV) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Human Papillomavirus(HPV) Vaccines Products Offered
12.2.5 GSK Recent Development
12.3 Walvax
12.3.1 Walvax Corporation Information
12.3.2 Walvax Description and Business Overview
12.3.3 Walvax Human Papillomavirus(HPV) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Walvax Human Papillomavirus(HPV) Vaccines Products Offered
12.3.5 Walvax Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Human Papillomavirus(HPV) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Human Papillomavirus(HPV) Vaccines Products Offered
12.11.5 Merck Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Human Papillomavirus(HPV) Vaccines Industry Trends
13.2 Human Papillomavirus(HPV) Vaccines Market Drivers
13.3 Human Papillomavirus(HPV) Vaccines Market Challenges
13.4 Human Papillomavirus(HPV) Vaccines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Papillomavirus(HPV) Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Human Papillomavirus(HPV) Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of 2-Valent Vaccine
    Table 3. Major Manufacturers of 4-Valent Vaccine
    Table 4. Global Human Papillomavirus(HPV) Vaccines Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 5. Global Human Papillomavirus(HPV) Vaccines Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Human Papillomavirus(HPV) Vaccines Sales by Regions (2016-2021) & (K Units)
    Table 7. Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Regions (2016-2021)
    Table 8. Global Human Papillomavirus(HPV) Vaccines Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Human Papillomavirus(HPV) Vaccines Sales Forecast by Region (2022-2027) & (K Units)
    Table 10. Global Human Papillomavirus(HPV) Vaccines Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Human Papillomavirus(HPV) Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Human Papillomavirus(HPV) Vaccines Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Human Papillomavirus(HPV) Vaccines Sales by Manufacturers (2016-2021) (K Units)
    Table 14. Global Human Papillomavirus(HPV) Vaccines Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Human Papillomavirus(HPV) Vaccines Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Human Papillomavirus(HPV) Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Human Papillomavirus(HPV) Vaccines Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Human Papillomavirus(HPV) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Human Papillomavirus(HPV) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus(HPV) Vaccines as of 2020)
    Table 20. Key Manufacturers Human Papillomavirus(HPV) Vaccines Price (2016-2021) (USD/Unit)
    Table 21. Human Papillomavirus(HPV) Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Human Papillomavirus(HPV) Vaccines Product Type
    Table 23. Date of International Manufacturers Enter into Human Papillomavirus(HPV) Vaccines Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Human Papillomavirus(HPV) Vaccines Sales by Type (2016-2021) (K Units)
    Table 26. Global Human Papillomavirus(HPV) Vaccines Sales Share by Type (2016-2021)
    Table 27. Global Human Papillomavirus(HPV) Vaccines Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Human Papillomavirus(HPV) Vaccines Revenue Share by Type (2016-2021)
    Table 29. Human Papillomavirus(HPV) Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Table 30. Global Human Papillomavirus(HPV) Vaccines Sales Forecast by Type (2022-2027) & (K Units)
    Table 31. Global Human Papillomavirus(HPV) Vaccines Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Human Papillomavirus(HPV) Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Human Papillomavirus(HPV) Vaccines Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Human Papillomavirus(HPV) Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
    Table 35. Global Human Papillomavirus(HPV) Vaccines Sales by Application (2016-2021) (K Units)
    Table 36. Global Human Papillomavirus(HPV) Vaccines Sales Share by Application (2016-2021)
    Table 37. Global Human Papillomavirus(HPV) Vaccines Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Human Papillomavirus(HPV) Vaccines Revenue Share by Application (2016-2021)
    Table 39. Human Papillomavirus(HPV) Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Table 40. Global Human Papillomavirus(HPV) Vaccines Sales Forecast by Application (2022-2027) & (K Units)
    Table 41. Global Human Papillomavirus(HPV) Vaccines Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Human Papillomavirus(HPV) Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Human Papillomavirus(HPV) Vaccines Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Human Papillomavirus(HPV) Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
    Table 45. China Human Papillomavirus(HPV) Vaccines Sales (K Units) of Key Companies (2016-2021)
    Table 46. China Human Papillomavirus(HPV) Vaccines Sales Share by Company (2016-2021)
    Table 47. China Human Papillomavirus(HPV) Vaccines Revenue (US$ Million) by Company (2016-2021)
    Table 48. China Human Papillomavirus(HPV) Vaccines Revenue Share by Company (2016-2021)
    Table 49. China Human Papillomavirus(HPV) Vaccines Sales (K Units) by Type (2016-2021)
    Table 50. China Human Papillomavirus(HPV) Vaccines Sales Share by Type (2016-2021)
    Table 51. China Human Papillomavirus(HPV) Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. China Human Papillomavirus(HPV) Vaccines Price (USD/Unit) by Type (2016-2021)
    Table 53. China Human Papillomavirus(HPV) Vaccines Sales (K Units) by Type (2022-2027)
    Table 54. China Human Papillomavirus(HPV) Vaccines Sales Share by Type (2022-2027)
    Table 55. China Human Papillomavirus(HPV) Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. China Human Papillomavirus(HPV) Vaccines Revenue Share by Type (2022-2027)
    Table 57. China Human Papillomavirus(HPV) Vaccines Price (USD/Unit) by Type (2022-2027)
    Table 58. China Human Papillomavirus(HPV) Vaccines Sales (K Units) by Application (2016-2021)
    Table 59. China Human Papillomavirus(HPV) Vaccines Sales Share by Application (2016-2021)
    Table 60. China Human Papillomavirus(HPV) Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. China Human Papillomavirus(HPV) Vaccines Price (USD/Unit) by Application (2016-2021)
    Table 62. China Human Papillomavirus(HPV) Vaccines Sales (K Units) by Application (2022-2027)
    Table 63. China Human Papillomavirus(HPV) Vaccines Sales Share by Application (2022-2027)
    Table 64. China Human Papillomavirus(HPV) Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. China Human Papillomavirus(HPV) Vaccines Revenue Share by Application (2022-2027)
    Table 66. China Human Papillomavirus(HPV) Vaccines Price (USD/Unit) by Application (2022-2027)
    Table 67. North America Human Papillomavirus(HPV) Vaccines Sales by Country (2016-2021) & (K Units)
    Table 68. North America Human Papillomavirus(HPV) Vaccines Sales Market Share by Country (2016-2021)
    Table 69. North America Human Papillomavirus(HPV) Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Human Papillomavirus(HPV) Vaccines Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Human Papillomavirus(HPV) Vaccines Sales by Region (2016-2021) & (K Units)
    Table 72. Asia Pacific Human Papillomavirus(HPV) Vaccines Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Human Papillomavirus(HPV) Vaccines Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Human Papillomavirus(HPV) Vaccines Revenue Market Share by Region (2016-2021)
    Table 75. Europe Human Papillomavirus(HPV) Vaccines Sales by Country (2016-2021) & (K Units)
    Table 76. Europe Human Papillomavirus(HPV) Vaccines Sales Market Share by Country (2016-2021)
    Table 77. Europe Human Papillomavirus(HPV) Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Human Papillomavirus(HPV) Vaccines Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Human Papillomavirus(HPV) Vaccines Sales by Country (2016-2021) & (K Units)
    Table 80. Latin America Human Papillomavirus(HPV) Vaccines Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Human Papillomavirus(HPV) Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Human Papillomavirus(HPV) Vaccines Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Human Papillomavirus(HPV) Vaccines Sales by Country (2016-2021) & (K Units)
    Table 84. Middle East and Africa Human Papillomavirus(HPV) Vaccines Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Human Papillomavirus(HPV) Vaccines Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Human Papillomavirus(HPV) Vaccines Revenue Market Share by Country (2016-2021)
    Table 87. Merck Corporation Information
    Table 88. Merck Description and Business Overview
    Table 89. Merck Human Papillomavirus(HPV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 90. Merck Human Papillomavirus(HPV) Vaccines Product
    Table 91. Merck Recent Development
    Table 92. GSK Corporation Information
    Table 93. GSK Description and Business Overview
    Table 94. GSK Human Papillomavirus(HPV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 95. GSK Product
    Table 96. GSK Recent Development
    Table 97. Walvax Corporation Information
    Table 98. Walvax Description and Business Overview
    Table 99. Walvax Human Papillomavirus(HPV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 100. Walvax Product
    Table 101. Walvax Recent Development
    Table 102. Human Papillomavirus(HPV) Vaccines Market Trends
    Table 103. Human Papillomavirus(HPV) Vaccines Market Drivers
    Table 104. Human Papillomavirus(HPV) Vaccines Market Challenges
    Table 105. Human Papillomavirus(HPV) Vaccines Market Restraints
    Table 106. Human Papillomavirus(HPV) Vaccines Customers List
    Table 107. Human Papillomavirus(HPV) Vaccines Distributors List
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Papillomavirus(HPV) Vaccines Product Picture
    Figure 2. Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Type in 2020 & 2027
    Figure 3. 2-Valent Vaccine Product Picture
    Figure 4. 4-Valent Vaccine Product Picture
    Figure 5. Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Application in 2020 & 2027
    Figure 6. Research & Academic Laboratories
    Figure 7. Pharmaceutical & Biotechnology Companies
    Figure 8. Others
    Figure 9. Human Papillomavirus(HPV) Vaccines Report Years Considered
    Figure 10. Global Human Papillomavirus(HPV) Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Human Papillomavirus(HPV) Vaccines Market Size 2016-2027 (US$ Million)
    Figure 12. Global Human Papillomavirus(HPV) Vaccines Sales 2016-2027 (K Units)
    Figure 13. Global Human Papillomavirus(HPV) Vaccines Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Region (2016-2021)
    Figure 15. Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Region in 2020
    Figure 16. Global Human Papillomavirus(HPV) Vaccines Revenue Market Share by Region (2016-2021)
    Figure 17. Global Human Papillomavirus(HPV) Vaccines Revenue Market Share by Region in 2020
    Figure 18. Global Human Papillomavirus(HPV) Vaccines Sales Share by Manufacturer in 2020
    Figure 19. The Top 10 and 5 Players Market Share by Human Papillomavirus(HPV) Vaccines Revenue in 2020
    Figure 20. Human Papillomavirus(HPV) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 21. Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Type (2016-2021)
    Figure 22. Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Type in 2020
    Figure 23. Global Human Papillomavirus(HPV) Vaccines Revenue Market Share by Type (2016-2021)
    Figure 24. Global Human Papillomavirus(HPV) Vaccines Revenue Market Share by Type in 2020
    Figure 25. Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Application (2016-2021)
    Figure 26. Global Human Papillomavirus(HPV) Vaccines Sales Market Share by Application in 2020
    Figure 27. Global Human Papillomavirus(HPV) Vaccines Revenue Market Share by Application (2016-2021)
    Figure 28. Global Human Papillomavirus(HPV) Vaccines Revenue Market Share by Application in 2020
    Figure 29. China Human Papillomavirus(HPV) Vaccines Sales Growth Rate 2016-2027 (K Units)
    Figure 30. China Human Papillomavirus(HPV) Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 31. China Human Papillomavirus(HPV) Vaccines Market Share in Global Market 2016-2027
    Figure 32. China 5 and 10 Largest Human Papillomavirus(HPV) Vaccines Players Market Share by Revenue in Human Papillomavirus(HPV) Vaccines in 2020
    Figure 33. China Human Papillomavirus(HPV) Vaccines Revenue Share by Type (2016-2021)
    Figure 34. China Human Papillomavirus(HPV) Vaccines Revenue Growth Rate by Type in 2016 & 2020
    Figure 35. China Human Papillomavirus(HPV) Vaccines Revenue Share by Application (2016-2021)
    Figure 36. China Human Papillomavirus(HPV) Vaccines Revenue Growth Rate by Application in 2016 & 2020
    Figure 37. North America Human Papillomavirus(HPV) Vaccines Sales Growth Rate 2016-2021 (K Units)
    Figure 38. North America Human Papillomavirus(HPV) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 39. North America Human Papillomavirus(HPV) Vaccines Sales Market Share by Country in 2020
    Figure 40. North America Human Papillomavirus(HPV) Vaccines Revenue Market Share by Country in 2020
    Figure 41. U.S. Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 42. U.S. Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Canada Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 44. Canada Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Europe Human Papillomavirus(HPV) Vaccines Sales Growth Rate 2016-2021 (K Units)
    Figure 46. Europe Human Papillomavirus(HPV) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 47. Europe Human Papillomavirus(HPV) Vaccines Sales Market Share by Country in 2020
    Figure 48. Europe Human Papillomavirus(HPV) Vaccines Revenue Market Share by Country in 2020
    Figure 49. Germany Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 50. Germany Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 51. France Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 52. France Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. U.K. Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 54. U.K. Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. Italy Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 56. Italy Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Russia Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 58. Russia Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Asia Pacific Human Papillomavirus(HPV) Vaccines Sales Growth Rate 2016-2021 (K Units)
    Figure 60. Asia Pacific Human Papillomavirus(HPV) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 61. Asia Pacific Human Papillomavirus(HPV) Vaccines Sales Market Share by Region in 2020
    Figure 62. Asia Pacific Human Papillomavirus(HPV) Vaccines Revenue Market Share by Region in 2020
    Figure 63. China Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 64. China Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 65. Japan Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 66. Japan Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. South Korea Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 68. South Korea Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. India Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 70. India Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. Australia Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 72. Australia Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. China Taiwan Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 74. China Taiwan Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Indonesia Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 76. Indonesia Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Thailand Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 78. Thailand Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Malaysia Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 80. Malaysia Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Latin America Human Papillomavirus(HPV) Vaccines Sales Growth Rate 2016-2021 (K Units)
    Figure 82. Latin America Human Papillomavirus(HPV) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 83. Latin America Human Papillomavirus(HPV) Vaccines Sales Market Share by Country in 2020
    Figure 84. Latin America Human Papillomavirus(HPV) Vaccines Revenue Market Share by Country in 2020
    Figure 85. Mexico Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 86. Mexico Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 87. Brazil Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 88. Brazil Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 89. Argentina Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 90. Argentina Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Middle East and Africa Human Papillomavirus(HPV) Vaccines Sales Growth Rate 2016-2021 (K Units)
    Figure 92. Middle East and Africa Human Papillomavirus(HPV) Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 93. Middle East and Africa Human Papillomavirus(HPV) Vaccines Sales Market Share by Country in 2020
    Figure 94. Middle East and Africa Human Papillomavirus(HPV) Vaccines Revenue Market Share by Country in 2020
    Figure 95. Turkey Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 96. Turkey Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 97. Saudi Arabia Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 98. Saudi Arabia Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 99. UAE Human Papillomavirus(HPV) Vaccines Sales Growth Rate (2016-2021) (K Units)
    Figure 100. UAE Human Papillomavirus(HPV) Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. Human Papillomavirus(HPV) Vaccines Value Chain
    Figure 102. Channels of Distribution
    Figure 103. Distributors Profiles
    Figure 104. Bottom-up and Top-down Approaches for This Report
    Figure 105. Data Triangulation
    Figure 106. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3900

This license allows only one user to access the PDF.
Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Paroxetine Hydrochloride Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36M7629
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Felodipine Sustained-Release Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36A7630
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Sertraline Hydrochloride Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25H7597
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Escitalopram Oxalate Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11E7869
Thu Mar 28 00:00:00 UTC 2024

Add to Cart